Human growth hormone use in poor ovarian response - caution and opportunities.

In addition, there may be significant publication bias in that negative studies may not be reported and the difficulty in doing controlled studies due to the substantial expense of growth hormone added to an already expensive IVF cycle.

also in 13,097 other papers